Information Library
Results for: Faster product development - Our Expertise
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Understanding the Complexity of HTA Networks
Presentation — November 27, 2011
As stakeholders’ influence shifts, demonstrating value is imperative for the success of every pharmaceutical product. Learn more about Quintiles HTA Watch service. -
Quintiles Strengthens Late Phase Offerings with Acquisition of Outcome Sciences, Inc.
Press Release — October 19, 2011 – With late phase (Phase IIIB and Phase IV) research becoming increasingly important to multiple healthcare stakeholders, Quintiles has acquired Outcome Sciences, Inc. (Outcome).
-
A Focus on CNS
Brochure — July 1, 2011
Quintiles is your ally for broad and deep CNS expertise in every aspect of the drug development process. -
Pharmacobiomics and Infectious Disease: Progress and Opportunities
White Paper — November 2, 2010
Pharmacobiomics and Infectious Disease: Progress Opportunities. After decades of work mapping the human genome, we are beginning to reap real benefits. -
Advancing Clinical Research in Alzheimer's Disease
White Paper — October 18, 2010
This report from Quintiles’ own Alzheimer’s experts gives you an inside look at the news from ICAD 2010. -
EXAMINING REAL-TIME DATA TO IMPROVE THE QUALITY AND EFFICIENCY OF DRUG DEVELOPMENT
Press Release — October 13, 2010 – White Paper authors explore how real-time data can enhance patient safety, strengthen quality and accelerate development timelines.
-
Is a REMS Request from FDA More Likely for Drugs & Biologics Indicated for Pediatric Use?
White Paper — October 8, 2010
Is a REMS Request From FDA More Likely For Drugs and Biologics Indicated for Pediatric Use? -
Using Real-Time Data to Drive Better Decisions, Faster
White Paper — September 30, 2010
This white paper examines the advantages afforded by access to real-time data during the course of a clinical trial. -
The Evolving Role of Neuroimaging in Future AD Clinical Trials
Video — September 21, 2010
Watch the video of Philip Scheltens's, MD of VU Medical Center recent presentation, The Evolving Role of Neuroimaging in Future AD Clinical Trials from the Quintiles Symposium at ICAD 2010. -
Navigating Future Challenges in Alzheimer's Disease Trials
White Paper — September 21, 2010
Quintiles’ own Alzheimer’s experts, Amir Kalali, Roza Hayduk and Lynne Hughes, sum up the insights and discoveries that could lead to the next breakthrough for Alzheimer’s disease.
